During development, neurons are guided to their targets by shortand long-range attractive and repulsive cues. MICAL, a large multidomain protein, is required for the combined action of semaphorins and plexins in axon guidance. Here, we present the structure of the N-terminal region of MICAL (MICAL fd) determined by x-ray diffraction to 2.0 Å resolution. The structure shows that MICAL fd is an FAD-containing module structurally similar to aromatic hydroxylases and amine oxidases. In addition, we present biochemical data that show that MICAL fd is a flavoenzyme that in the presence of NADPH reduces molecular oxygen to H 2O2 (Km,NAPDH ‫؍‬ 222 M; kcat ‫؍‬ 77 sec ؊1 ), a molecule with known signaling properties. We propose that the H 2O2 produced by this reaction may be one of the signaling molecules involved in axon guidance by MICAL.
D
uring neural development, axons are guided to their targets by a variety of environmental cues. These guidance cues may take the form of long-range signaling by diffusible molecules or shortrange interactions by membrane-bound molecules, which either attract or repel the axon. One family of effector molecules, the semaphorins, includes secreted and transmembrane proteins that act as repellents in a variety of axon development processes. Repulsive guidance by semaphorins is mediated through their interaction with plexins, a family of transmembrane proteins that function as their receptors (1) . It was shown recently that, in Drosophila, a large multidomain cytosolic protein, MICAL, is required for the repulsive axon guidance mediated by interaction of Semaphorin 1a and Plexin A (2) .
Since the MICAL family of proteins was first identified, family members have been implicated in a variety of cellular processes ranging from vesicle trafficking to association with intermediate filaments in mesenchymal cells to involvement in axon pathfinding (2) (3) (4) . Three MICAL genes (MICAL-1 to -3) have been identified in mammals and one in Drosophila (2) . In all cases, MICAL is a Ͼ1,000-aa protein that contains a large N-terminal domain, followed by a calponin homology (CH) domain, a LIM domain (double Zn-finger), a proline-rich domain, and a coiled-coil ERM ␣-like motif (2) . This domain architecture, conserved among fly, mouse, and human family members (2) , explains the large number of protein-protein associations involving MICAL that have been observed. The proline-rich domain in human MICAL-1 was shown to be a binding site for CasL, a molecule in the ␤1 integrin signaling cascade (5) . (The name MICAL derives from Molecule Interacting with CasL.) The CH and LIM domains (5) have been implicated in signal transduction and cytoskeletal organization (6, 7) . Finally, the N-terminal portion of MICAL is an FAD-binding domain that has sequence motifs characteristic of monooxygenases (2) .
Yeast two-hybrid assays and immunoprecipitation experiments showed that Drosophila MICAL (D-MICAL) binds to the Plexin A receptor via its C-terminal coiled-coil motif (2) . Classical genetic analysis indicated that D-MICAL mediates Sema-1a-induced defasciculation, branching, and general axon pathfinding (2) . Genetic analysis of flies carrying a mutation in the FAD-binding domain of D-MICAL indicated that this domain is necessary for Sema-1a signaling. Finally, Terman et al. (2) showed that flavoprotein monooxygenase inhibitors were able to abrogate the repulsive guidance response in rat nerve growth factor-dependent dorsal root ganglion axons. These findings were interpreted as indicating that MICAL's axon guidance activity may be mediated by its putative monooxygenase activity.
Flavoprotein monooxygenases contain a characteristic Nterminal GxGxxG consensus sequence that is required for FAD binding (8) . MICAL contains this sequence but lacks an identifiable NADPH͞NADH-binding consensus sequence (2) , reminiscent of the glutathione reductase (GR 2 ) oxidoreductase family members (8) . Because no substrate has been identified for the MICAL FAD-binding domain (MICAL fd ), various hypotheses linking MICAL's enzymatic activity with cytoskeletal reorganization were proposed (2, 9), including direct oxidation and destabilization of actin filaments, production of reactive oxygen species that affect downstream signaling molecules, and direct oxidation of other signaling molecules (9) .
Despite extensive investigation, questions related to substrate identity, mechanism of action, and the interactions of MICAL fd with other domains within MICAL remain unanswered. In this article, we report the determination of the structure of the FADbinding domain of mouse MICAL-1 (MICAL fd ). In addition, we determined that in the presence of NADPH and molecular oxygen, MICAL fd uses the reducing equivalents of NADPH to produce H 2 O 2 , a molecule that may be acting as a neuron guidance signal.
Materials and Methods
Cloning and Mutational Surface Engineering. A plasmid containing cDNA coding for residues 1-484 of MICAL1 from Mus musculus (accession no. BC021477) was cloned into the pET28a expression vector that contains an N-terminal 6ϫ His-tag. After extensive unsuccessful crystallization trials, surface-site mutations (K141A and K142A) were made within the same construct to enhance crystallization (10) (11) (12) (13) . Mutations were introduced with the QuikChange Site-Directed Mutagenesis kit (Stratagene).
(1 units͞ml) at room temperature to remove the His-tag. The cleaved product was purified by using a Source S15 cation exchange column, eluting with a gradient of 20 mM Hepes, 0.1-1 M NaCl, and 1 mM DTT (pH 7). The final yield was Ϸ10 mg per liter of culture. The purified protein has an absorbance spectrum with peaks at 360 and 460 nm (2) . For crystallization, 1 l of protein solution [4 mg͞ml in 20 mM Hepes, 100 mM NaCl, and 1 mM DTT (pH 7)] was combined with 1 l of reservoir solution [100 mM NaOAc (pH 4.6), 23.5% PEG 2000 MME, and 0.3 M (NH 4 ) 2 SO 4 ] and equilibrated against 0.5 ml of reservoir solution. Crystals (Ϸ50 ϫ 300 ϫ 300 m) grew in 24 h at 20°C. MICAL fd crystals were frozen in 100 mM NaOAc (pH 4.6), 42% PEG 2000 MME, and 0.3 M (NH 4 ) 2 SO 4 . For heavy atom preparation, crystals were soaked in 10 l of reservoir solution supplemented with heavy atom compounds. MICAL fd crystals soaked with 1 mM PCMBS (p-chloromercuribenzene sulfonate) for 2 h were used for phase determination.
Data Collection, Structure Determination, and Refinement. Diffraction data of both native and heavy atom-containing crystals, collected at Brookhaven National Laboratory beamlines X6A and X29, were processed with HKL2000 (14) . Isomorphous and anomalous differences of the PCMBS derivative (Table 1) were used to calculate phases with the program SOLVE (15) . Phases were improved and extended in the range 30-2.5 Å by density modification with the program RESOLVE (15) . After automatic (15) and manual building with O (16-18), the local symmetry and the molecular envelope were identified [Uppsala Software Factory package (16) (17) (18) ] and used for map improvement by density averaging with the program DM. The structure was refined by using data from 50 to 2.0 Å with the program REFMAC (19) . A subset of 5% of the data was used for cross-validation. After rebuilding and several rounds of positional and atomic B-factor refinement (maximum-likelihood residual), solvent molecules were added with the program ARP/ WARP (20) and manually. A solvent electron density larger than a water molecule present in a highly positively charged pocket was interpreted as a chloride ion. The final rounds of refinement were carried out by using translation, libration, screw-rotation (TLS) refinement (21) as implemented in REFMAC5. The final model contained 951 amino acids spanning residues 8-146 and 151-484 (monomer A) and residues 1-146, 152-264, and 266-484 (monomer B), two FAD molecules, a chloride ion, and 617 water molecules (Table 1) .
Drawings were prepared with MOLSCRIPT (22) , PYMOL (23), GRASP (24), POVRAY (25) , ESPRIPT (26), and VMD (27).
Sedimentation Velocity Analysis. The molar mass and sedimentation coefficient of MICAL fd were analyzed by using a Beckman Coulter XL-I analytical ultracentrifuge. Samples contained 4 mg͞ml MI-CAL fd in 20 mM Hepes, 100 mM NaCl, and 1 mM BME (pH 7.0). Reference and sample solutions were loaded into double-sector centerpieces and mounted in a Beckman An-50 Ti rotor. Experiments were performed at 4°C and 20°C with a rotor speed of 50,000 rpm. Sample absorbances at 295 and 370 nm were monitored in a continuous mode with no delay and a step size of 0.003 cm without averaging. Multiple scans at different time points were fit to a continuous size distribution by using SEDFIT (28) . The c(s) distribution in SEDFIT was exported to SEDPHAT, where experimental values were corrected to S 20,w . A partial specific volume of 0.7426 was used in all calculations based on the amino acid sequence of the protein. The solvent density and viscosity were calculated by using SEDNTERP (29) .
Kinetic Studies. The UV-visible absorption changes in the reactions of MICAL fd were monitored at 298 K with a Cary 50 Bio UVVisible spectrophotometer. Enzyme activity was monitored by the rate of NAD(P)H oxidation ( 340 ϭ 6.2 mM Ϫ1 ⅐cm Ϫ1 ), and the rate of H 2 O 2 production was measured by using the Amplex Red hydrogen peroxide͞peroxidase assay kit (catalog no. A-22188, Molecular Probes; 560 ϭ 44.3 mM Ϫ1 ⅐cm Ϫ1 ). Absorbance values were measured over a period of 5 min.
Assays were carried out in 110 l of a solution containing 20 mM Hepes, 100 mM NaCl (pH 7), and 6.02 nM MICAL fd . In assays measuring the K m and k cat for NAD(P)H oxidation, NAD(P)H was added at concentrations ranging from 20 to 500 M. For the inhibition studies, inhibitor (Ϫ)-epigallocatechin gallate (EGCG) was added at concentrations of 30 and 60 M, and initial rates measured at NADPH concentrations varied from 20 to 200 M.
Results
Structure Determination. Crystals obtained under several conditions with the wild-type protein were not suitable for x-ray diffraction studies. To favor the formation of other crystal forms, we mutated two surface lysines (K141A and K142A) (12) that were inferred by sequence analysis to be on the surface of the protein. (The structure determination confirmed that the two residues were on the surface of the protein far from the active site.) Well diffracting crystals of the mutated protein were readily obtained. They contain two molecules in the asymmetric unit and have a solvent content of 47%. The structure was determined by using a single isomorphous heavy atom derivative including its anomalous signal ( Table 1 ). The final model was refined with data to 2.0 Å resolution to an R-value of 19.2% (R free ϭ 26.6%) with excellent geometry. Description of the Structure. MICAL fd is a mixed ␣͞␤ protein that contains both parallel and antiparallel ␤-sheets (Fig. 1A) . It is composed of two subdomains of different sizes linked by two ␤-strands (␤9 and ␤15; residues 227-233 and 367-373) (Fig. 1B) . The large subdomain (domain-1; residues 1-226 and 373-484) contains the two FAD sequence motifs (residues 84-114 and 386-416) and a third conserved motif (residues 212-225) (2). The first sequence, which contains the GXGXXG motif (Fig. 2) , is part of a Rossmann ␤-␣-␤ fold (␤1-␣5-␤2 in MICAL fd ; Fig. 1B ). This is a sequence commonly found in FAD-and NAD(P)H-dependent oxidoreductases (8). The second motif, which contains the conserved GD sequence in hydroxylases, forms part of a strand and a helix (␤17 and ␣15). In MICAL fd , this second conserved sequence (30) , makes contacts with the ribose moiety of FAD in a manner similar to that observed in the rubredoxin reductase of Pseudomonas oleovorans (31) . The third conserved motif is part of a ␤-strand (␤8) and the following loop. In domain-1, residues 1-71 form two perpendicular helical hairpins (helices ␣1-␣4) that connect to the central strand (␤1) of the major parallel ␤-sheet. This sheet, composed of five parallel strands (␤1, ␤2, ␤5, ␤8, and ␤17) and one antiparallel strand (␤16), is centrally located within the molecule. The small subdomain (domain-2; residues 238-366) is inserted between strands ␤8 and ␤16 of this main sheet. It contains a five-stranded antiparallel ␤-sheet (␤10-␤14) and several connecting helices (␣10-␣14). Two additional strands, one at the beginning (␤9) and one at the end (␤15) of this domain, form a two-stranded sheet that makes main chain H-bonds with the equivalent two-stranded sheet of another monomer in the crystal asymmetric unit (see below). Several other elements complete the structure of MICAL fd , including a C-terminal helical hairpin that ends in an additional short helix (Fig. 1B) .
Structural Similarity to Other FAD-Containing Enzymes. The fold of MICAL fd is similar to that of other FAD-requiring enzymes. A DALI search of known structures revealed that the protein is most similar to aromatic hydroxylases, especially the p-hydroxybenzoate hydroxylase (pHBH) from Pseudomonas fluorescens (rms 1.79 Å for 199 of 484 aligned ␣-carbons) (32). It is clear from the fraction of aligned residues that, although the two proteins share large portions of their folds, many of the regions connecting the elements of secondary structure diverge between the two proteins (Fig. 2) . In particular, the bacterial hydroxylase lacks the two N-terminal helical hairpins of MICAL fd . The sequence identity between the two proteins is only 5% for the whole sequence and 11% for the structurally matched residues. A portion of the MICAL fd fold is also shared by amine oxidases, the most similar of which is the human monoamine oxidase B (rms 1.85 Å for 116 aligned ␣-carbons; sequence identity: total 5%, matched residues 21%) (33, 34) . The three proteins share core ␤-sheets and helices (Fig. 2) and diverge in stretches connecting secondary structure elements. The monoamine oxidase differs from the monooxygenases in two significant ways: (i) it contains an additional 100-residue helical domain between ␣7 and ␤4 (not shown in Fig. 2) ; and (ii) the loop connecting strand ␤17 to helix ␣15 (residues 390-405) is shorter in monoamine oxidase, allowing the isoalloxazine ring of the FAD to move 3.5 Å closer to the center of molecule. This displacement enlarges the active site cavity above the position of the FAD N5, allowing the covalent attachment of long amine substrates.
MICALfd Is a Monomer. The crystallographic asymmetric unit of the crystals used in this study contains two MICAL fd molecules related by a local twofold axis of symmetry. A continuous four-stranded ␤-sheet (␤15-␤9-␤9Ј-␤15Ј; primes refer to the second monomer) extends across the dimer interface, with two equivalent ␤9-strands (residues 228-233), one from each monomer, making six main chain H-bonds to each other and burying 1,601 Å 2 . This arrangement suggested that the active form of MICAL might be a dimer. However, sedimentation velocity experiments at 4°C and 20°C with an analytical ultracentrifuge showed that in a 80 M protein solution (4 mg͞ml, the concentration used in the crystallization experiments), MICAL fd behaves as a monomer with no indication of the presence of dimers (Fig. 3) . (Fig. 1 A) . The isoalloxazine ring is highly planar, and its dimethyl benzene and middle rings stack almost perfectly with the indole moiety of Trp-400 (Fig. 4 A and B) , a residue within the region of the second conserved sequence motif. The side chain of Asn-123 makes hydrogen bonds to N5 and O4 of the isoalloxazine, and O4 also makes a hydrogen bond to the OH of Tyr-293. The ribitol moiety extends in a direction almost perpendicular to the isoalloxazine, bending at C5Ј before connecting to the diphosphate. O2Ј forms an H-bond to the guanidinium of Arg-121 and O3Ј to the carboxylate of Asp-393 of the second motif. The ribitol phosphate makes H-bonds to the main chain NHs of Asp-393 and Cys-95 of the first motif. The ribose phosphate makes two H-bonds to the guanidinium of Arg-121. Glu-114 (first motif) makes H-bonds to O2Ј and O3Ј of the ribose. O2Ј also makes an H-bond to the guanidinium group of Arg-116. The adenine ring stacks against the extended aliphatic side chain of Lys-115, with N6 making an H-bond to the main chain NH of Phe-181.
The edges of the pyrimidine and middle rings of the FAD are exposed to solvent through separate openings at either side of the protein. This exposure is in contrast to other monooxygenases, in which the path for accessing the isoalloxazine ring is from only one side and is usually less open than either opening of MICAL fd (32) (33) (34) . All donors and acceptors of the pyrimidine ring make H-bonds with either protein atoms or water molecules (Fig. 4A) .
The conformation of the FAD in the structure reported here is equivalent to the oxidized, ''out'' conformation in the bacterial pHBH (35) (36) (37) . In reduced pHBH the FADH 2 adopts an ''in'' conformation that occupies a volume surrounded by the glycine residues of the second conserved motif. This ''in'' conformation cannot accomodate larger side chains at these positions, explaining the high conservation of this motif. MICAL fd has the same four glycines (Fig. 2) and therefore has the same available space adjacent to these residues but in the oxidized form reported here is occupied by waters. However, it is possible for the reduced isoalloxazine to pivot around the C4Ј-C5Ј bond of ribitol and swing into this volume (Fig. 4C) , displacing the occupying water molecules.
Identification of an Enzymatic Activity of MICALfd. The strong structural similarity of MICAL fd to the P. fluorescens p-hydroxybenzene hydroxylase suggested that the two proteins might have similar enzymatic activities. Because, as isolated, MICAL fd contains oxidized FAD, reduction of the cofactor was tested by using either NADH or NADPH. Under the conditions of the experiment, although no net reduction of the FAD was detected (data not shown), a steady, time-dependent oxidation of reduced nicotinamide dinucleotide was observed (Fig. 5A ). This observation suggested that enzyme-bound FADH 2 was formed but was then reoxidized by oxygen. The resulting production of H 2 O 2 was confirmed by monitoring its formation with horseradish peroxidase in the presence of 10-acetyl-3,7-dihydroxyphenoxazine (Fig. 5A) . The rate of reaction was Ͼ10 times faster with 200 M NADPH than with 200 M NADH (data not shown), suggesting that MICAL is probably an NADPH-dependent enzyme.
The origin of this activity may correspond to one of three cases. First, that H 2 O 2 is the physiological product of the enzyme and is a component of the avoidance signal. Second, as with other FAD hydroxylases, in the absence of substrate the hydroperoxide form of the enzyme (the MICAL fd -FADH-O 2 H intermediate) decomposes, producing hydrogen peroxide and oxidized enzyme-bound FAD (Scheme 1). Third, the enzyme may actually be an amine oxidase in which the FADH 2 is reoxidized by molecular oxygen, and the reduction by NADPH is a fortuitous, nonspecific reaction. Although this last case is unlikely, discrimination among these possibilities requires further experimentation.
Kinetics and Inhibition of MICALfd. Kinetic characterization of MICAL fd was carried out by measuring the rate of oxidation of NAD(P)H for concentrations between 20 and 500 M. Analysis of the data showed that the k cat for H 2 O 2 production is 77 sec Ϫ1 and the K m of NADPH is 222 M (Fig. 5A Inset) . The optimum pH of this activity is Ϸ7 (Fig. 5B) . A monooxygenase inhibitor, EGCG, has been shown to inhibit the axon guidance activity of MICAL (2) . In the presence of NADPH, EGCG inhibits H 2 O 2 production by MICAL fd with an inhibition constant (K i ) of 2 M. The inhibition by EGCG is noncompetitive with respect to NADPH (Fig. 5C ), indicating that EGCG does not bind to the NADPH site.
Binding of NADPH to MICALfd. Mechanistically, NADPH must bind to the oxidized form of the enzyme. In this form, there is a cavity at the exposed end of the pyrimidine ring of the FAD that is lined with positively charged residues (arginines 136, 158, 356, and 116, and lysine 118; Fig. 6 ). A Cl Ϫ ion found in this region of the structure may occupy the position that the NADPH 2Ј-phosphate occupies in the complex.
Discussion
In Drosophila, the multidomain cytosolic protein MICAL is expressed in axons, where it interacts with the neuronal Plexin A receptor (2) . Expression of MICAL is required for Semaphorin 1a͞Plexin A-mediated repulsive axon guidance. It was shown that MICAL fd is required for MICAL's physiological function and that inhibitors of monooxygenase activity such as EGCG abate the action of MICAL (2) . We have demonstrated that MICAL fd can reduce molecular oxygen to H 2 O 2 using NADPH as the source of reducing equivalents, and that this activity is inhibited by EGCG.
The synthesis of a specific metabolite and the production of reactive oxygen species have been proposed previously as possible mechanisms of MICAL signaling (9) . We showed that the FADbinding domain of MICAL can generate at least the second kind of signals: MICAL reduces molecular oxygen using NADPH to produce H 2 O 2 , a possible signaling molecule in processes involving protein phosphorylation (38, 39) and direct actin modification (40) (41) (42) . Oxidation of actin has been shown to play a major role in actin remodeling. For example, G-actin oxidized by air (41) results in disulfide-bonded dimers that may be incorporated into F-actin filaments during assembly and allow for cross-linking between filaments. In vitro studies of exposure of G-actin to H 2 O 2 showed that several methionine residues may also be oxidized (43, 44) . Furthermore, oxidation of methionine and cysteine residues produces conformational changes within the actin molecule that may affect the integrity of the assembled F-actin. Thus, the action of hydrogen peroxide in axon guidance may be related to its ability to modify the biophysical characteristics of the cytoskeleton.
Independently of the mechanism, our observations relate the enzymatic activity of MICAL to its physiological function by identifying a small-molecule candidate that can act as a diffusible effector in axon guidance. In addition, hydrogen peroxide may react with endogenous small molecules and change their properties so they can act as additional signaling molecules. In addition to molecular oxygen, other endogenous molecules or their products of reaction with H 2 O 2 may also be substrates of MICAL resulting in additional signaling molecules. Thus, the results presented here offer a clear path for the identification of additional signaling small molecules active in axon guidance by MICAL. 
